Envista Holdings to Highlight Innovations at J.P. Morgan Healthcare Conference 2025
- Envista Holdings will present innovations at the J.P. Morgan Healthcare Conference on January 15, 2025.
- The company offers over 30 brands, focusing on dental implants, orthodontics, and digital imaging technologies.
- Envista prioritizes continuous improvement and innovation through its Envista Business System for better patient care.
Envista Holdings to Showcase Innovations at J.P. Morgan Healthcare Conference
Envista Holdings Corporation, a key player in the dental products industry, prepares to participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference scheduled for January 15, 2025. The company’s presentation will take place from 9:45 to 10:25 am PT at the Westin St. Francis Hotel in San Francisco. This event represents a platform for Envista to highlight its commitment to enhancing patient care through innovative dental solutions. An audio recording of the presentation will be made available on the company’s Investor Relations website for 30 days following the event, ensuring that stakeholders and interested parties can access the insights shared during the conference.
With a comprehensive portfolio that includes over 30 respected brands such as Nobel Biocare, Ormco, DEXIS, and Kerr, Envista is dedicated to meeting the diverse clinical needs of dental professionals. The company’s offerings span several key areas, including dental implants, orthodontics, digital imaging technologies, and dental consumables. By providing products designed to diagnose, treat, and prevent dental issues, Envista aims not only to improve oral health but also to enhance the aesthetics of smiles. This strategic focus positions Envista as a leading force within the dental market, allowing it to capture significant market shares in promising segments.
Central to Envista's operational excellence is the Envista Business System (EBS), which prioritizes continuous improvement and innovation while maintaining a strong customer-centric approach. The company’s experienced leadership team is well-equipped to navigate the complexities of the dental industry and respond effectively to the evolving needs of dental professionals worldwide. By fostering partnerships with dental practitioners, Envista reinforces its dedication to improving patient outcomes and advancing the standards of dental care.
In addition to its upcoming conference participation, Envista Holdings remains committed to enhancing its product offerings and expanding its market presence. The company's focus on innovation ensures that dental professionals have access to the latest technologies and solutions to provide optimal patient care. As the dental industry continues to evolve, Envista stands poised to lead the way in delivering high-quality products that address the needs of both practitioners and patients alike. For further inquiries, James Gustafson, Vice President of Investor Relations, is available at the company’s headquarters in Brea, California. More information about Envista and its extensive range of products can be found on their website at www.envistaco.com.